Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Health CarePharmaceuticals & Biotechnology
  • Price (USD)3.74
  • Today's Change0.135 / 3.74%
  • Shares traded882.82k
  • 1 Year change-38.49%
  • Beta1.6882
Data delayed at least 15 minutes, as of Jul 02 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

  • Revenue in USD (TTM)90.06m
  • Net income in USD-52.55m
  • Incorporated2000
  • Employees404.00
  • Location
    Pacific Biosciences of California Inc1305 O'brien DriveMENLO PARK 94025United StatesUSA
  • Phone+1 (650) 521-8000
  • Fax+1 (302) 636-5454
  • Websitehttps://www.pacb.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Establishment Labs Holdings Inc93.27m-45.13m431.58m602.00--4.78--4.63-2.12-2.124.433.870.67251.394.47154,930.20-32.54---37.87--63.35---48.39--5.45-4.070.3504--46.33---80.82------
Intersect ENT Inc102.30m-49.72m447.04m402.00--4.14--4.37-1.56-1.563.223.320.74411.527.40254,465.20-36.17-20.44-41.94-23.2176.9981.25-48.61-29.535.67--0.00--0.617723.11-87.57--58.98--
Antares Pharma Inc133.66m1.16m451.98m178.00395.658.40125.383.380.00690.00690.80930.3251.133.563.32750,882.000.9814-16.971.41-22.9559.1753.720.8649-20.682.551.170.4296--94.9036.1268.89---16.10--
AxoGen Inc107.69m-27.82m456.86m371.00--3.68--4.24-0.7055-0.70552.733.130.70531.497.63290,264.20-18.22-23.15-20.66-26.8480.8682.09-25.84-28.095.43--0.0004--27.1344.71-30.08--54.48--
SI-Bone Inc69.13m-41.83m457.96m262.00--3.94--6.62-1.64-1.642.724.090.46111.567.78263,858.80-27.90-39.61-31.06-46.8289.5989.25-60.51-50.267.59-14.780.2526--21.5310.94-120.04---3.15--
Owens & Minor, Inc.8.87bn-22.60m463.74m6.40k--,386,288.00-0.5949-1.05-0.9745-1.7111.7112.17-0.2547-0.35170.91051.040.781---2.20-0.490594.28---5.91-60.19
BioLife Solutions Inc33.76m16.28m467.16m151.0026.355.6219.8913.840.68240.68241.483.200.4721.576.07223,596.0028.27-31.9035.20-35.4365.4165.2059.90-57.980.61364.220.00--38.6434.6293.46--31.63--
TransMedics Group Inc26.46m-35.50m471.97m109.00--7.96--17.84-1.68-1.681.252.190.390.914.69242,733.90-52.33---67.99--61.04---134.19--5.34-8.550.4233--81.33---41.21------
Co-Diagnostics Inc1.76m-5.89m518.67m27.00--27.05--294.68-0.3311-0.33110.09540.69820.13231.693.2176,526.09-44.30-256.57-47.01-1,630.7466.2755.19-334.77-8,585.3015.86-33.430.00--438.64--1.21--56.95--
LeMaitre Vascular Inc119.30m17.60m531.79m454.0030.523.5722.864.460.86340.86345.857.380.6921.227.44262,784.2010.2112.4611.3914.0667.7969.5514.7515.393.28--0.0029.8011.0510.52-20.4535.5825.9019.21
MiMedx Group Inc321.14m52.73m551.62m753.0010.987.399.431.720.45470.55922.770.67492.042.579.47426,479.4033.538.8648.3812.2289.1088.9316.424.870.8575533.620.00--11.8243.42-156.86--27.08--
Pacific Biosciences of California Inc90.06m-52.55m577.12m404.00--9.53--6.41-0.3439-0.34390.58610.39240.42852.9712.33222,930.70-25.00-53.50-43.20-69.7641.0242.99-58.35-86.221.16-45.770.00--15.608.4517.97--12.00--
Varex Imaging Corp796.20m3.50m584.15m2.00k171.551.2813.910.73370.08710.087120.6011.670.77772.006.34398,100.000.38096.010.4687.1631.6836.040.48986.810.86721.470.4522--0.9312.64-23.65-32.44-3.12--
SurModics, Inc.100.60m6.63m585.05m369.0089.284.6841.895.820.48160.48167.319.180.65642.786.38272,623.304.334.604.865.1686.0984.896.597.895.39--0.000.0023.0411.74365.73-9.0624.26--
Orthofix Medical Inc455.67m-3.69m618.13m1.06k--1.7328.611.36-0.2226-0.222623.9318.650.93681.245.79431,910.90-0.75950.0757-0.87620.09477.9978.42-0.81070.07352.3844.070.06040.001.532.72-314.79--4.35--
Cryolife Inc275.15m-4.77m740.47m1.20k--2.6852.662.69-0.1286-0.12447.357.330.45561.875.34229,288.30-0.79520.816-0.85170.885166.4865.80-1.751.583.661.140.475820.815.0913.81150.90-26.348.70--
Data as of Jul 02 2020. Currency figures normalised to Pacific Biosciences of California Inc's reporting currency: US Dollar USD

Institutional shareholders

39.19%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 202010.72m6.96%
Bellevue Asset Management AGas of 31 Mar 20207.38m4.79%
The Vanguard Group, Inc.as of 31 Mar 20207.06m4.59%
Capital Research & Management Co. (International Investors)as of 31 Mar 20206.80m4.41%
Kite Lake Capital Management (UK) LLPas of 31 Mar 20205.49m3.56%
Capital Research & Management Co. (World Investors)as of 31 Mar 20205.45m3.54%
Water Island Capital LLCas of 31 Mar 20205.44m3.53%
Weiss Multi-Strategy Advisers LLCas of 31 Mar 20204.26m2.76%
ARK Investment Management LLCas of 31 Mar 20204.19m2.72%
SSgA Funds Management, Inc.as of 31 Mar 20203.58m2.33%
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.